BTA 0.00% 57.0¢ biota holdings limited

resistance, page-15

  1. 93 Posts.
    Thanks 202020,

    You have referred to this source:
    http://www.chinadaily.com.cn/bizchina/2009-11/16/content_8975738.htm
    GSK is CONSIDERING investing in a manufacturing facility to produce Relenza for the country, said the GSK's Reilly, declining to elaborate.

    What is the chance of GSK manufacturing in China when in 2006 they licensed Simcere but did not provide the know-how to manufacture Relenza and Simcere said it will take a long time for approval?

    "Test procedures for the drug Zanamivir are still being decided. It would take a long time to complete the clinical trials," said Xu Xiaoping, a member of the institute
    http://news.xinhuanet.com/english/2009-02/06/content_10772564.htm

    By the time the tests are completed and manufacturing commence, what is left of the Relenza patent? Chi-Renza - the Chinese version of the Indian Virenza.



 
watchlist Created with Sketch. Add BTA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.